Hepatology

Addiction Medicine

Questions discussed in this category

How do you evaluate and manage acute alcohol withdrawal when symptom-driven protocols are confounded/unreliable?

For instance, what do you do when patients have chronic tremors, cognitive impairment, hypertension, etc.?

3 Answers available

How do you counsel patients on the risks vs benefits of naltrexone for alcohol use disorder with persistently elevated liver enzymes?

Is there an absolute cutoff for AST/ALT that you use where the risks outweigh the potential harm reduction benefits of using the medication? &nbs...

2 Answers available

Is there a role for use of GLP-1/GIP receptor agonists in the management of substance use disorders, whether or not they meet other inclusion criteria for their use?

2 Answers available

Papers discussed in this category

Drug and alcohol dependence, 2024 Sep 07

Potential role of glucagon-like peptide-1 (GLP-1) receptor agonists in substance use disorder: A systematic review of randomized trials.

JAMA psychiatry, 2025 Apr 01

Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial.

JHEP reports : innovation in hepatology, 2024 Apr 10

Safety of naltrexone in patients with cirrhosis.

Related Topics in Hepatology